W
hat do health consumers know and how do they know it? Or perhaps more to the point, what do health consumers think they know, and how can we correct it?
Those questions are raised rather acutely in two revealing studies published in this issue of the Journal of General Internal Medicine -one by Wilson et al. on the use of antibiotics for acute respiratory illnesses, 1 and one by Bell et al. on direct-to-consumer prescription drug advertising. 2 It comes as little surprise, perhaps, to learn from Wilson and his colleagues that more than half (52%) of adult respondents in a Denver telephone survey stated (incorrectly) that antibiotics are an effective treatment for viral acute respiratory illnesses. However, there is even less comfort in learning that previous communication with a nurse advisor and being told that antibiotics were not necessary were both positively associated with previous antibiotic use.
In the case of direct-to-consumer advertising by pharmaceutical companies, Bell and his colleagues found, again not surprisingly, that the large amounts of money being pumped into television and print media to promote prescription drugs are having their intended effect. Of 329 adults surveyed in Sacramento County, the average respondent was aware of ads for 3.72 drugs in the survey list of 10 (1 of the 10 drugs was fabricated by the researchers, as a control measure, but only 3% fell for the bait by saying they had seen it advertised). Moreover, these respondents had acted on their awareness. Nearly one-fifth (19%) said they had requested a prescription for a drug based on a direct-to-consumer advertisement, while more than onethird (35%) said they had asked their physician about a drug they had seen advertised.
These statistics provide a fascinating backdrop against which to contemplate the stunning sums of money that are beginning to be poured into consumer health information and marketing. According to Bell et al., direct-to-consumer spending by pharmaceutical companies, which stood at $600 million in 1996, is projected to reach $7.5 billion in 2005. 2 What are consumers to make of the messages fueled by ad spending that eclipses the total spent by all political parties in a presidential election year?
According to Bell, many have a touching faith in their government's ability to keep it all straight. Half of the respondents thought-erroneously-that the government has prior approval of drug ads, while sizable minorities believed drugs have to be "completely safe" (43%) or "extremely effective" (21%) to be marketed direct-to-consumer.
Although neither of these papers explores the role of Internet and new media technologies in consumer health information and marketing, there is no doubt that the Web is the next frontier of consumer health information and marketing. Moreover, the Web has much in common with the wild, wild West in its current state of evolution. Egregious excesses in the marketing and sale of prescription drugs by Web site operators (including, e.g., two sites' dispensing of Viagra to a teenage Kansas boy armed with his mother's credit card and working with consumer protection agents) has led to an increasing amount of legal and regulatory action at both the state and federal level. In June, the Federal Trade Commission cracked down on four Web sites making spurious health claims and marketing alternative therapies, and in July, the U.S. House of Representatives held contentious hearings at which the U.S. Food and Drug Administration (FDA) pledged to double the number of staff assigned to monitor the Internet.
While it may be relatively easy to identify and tame the more outrageous outliers (at least those located within the reach of U.S. regulatory agencies), there will still remain the large gaps of understanding and communication that are thoughtfully explored in these two papers. These gapswhich exist now in the minds of those who communicate with nurses following telephone scripts, as well as in the minds of those who take the trouble to read lengthy print advertisements for new drugs-are just as likely to be found in the new media as they are in the old, if not more so.
Whether the number of American adults regularly accessing the Web for health information stands closer to 22.3 million, as Cyber Dialogue (New York, NY) reported late last year, or 60 million, as Louis Harris (Rochester, NY) found earlier this year, the number is vast and growing rapidly. And the same commercial considerations that fuel print and television ads are going to be applied to the Web. One research firm, Jupiter Communications (New York, NY), projects that consumers' online spending for prescription drugs will reach $966 million in 2003, while over-thecounter drugs will be purchased online to the tune of $314 million and vitamins and herbal supplements, $434 million.
Nor are the consumer health portals (i.e., gateway sites) on the World Wide Web shrinking from the need to market themselves on a colossal scale. Drkoop.com, named for the former U.S. Surgeon-General Dr. C. Everett Koop, has announced that it will pay America Online $89 million over the next four years to be the "premier" health information provider on the Web's most popular consumer service. In addition, Onhealth.com is spending $25 million this fall alone in advertising to drive viewers to its site, and WebMD.com has discussed plans to spend up to $200 million in advertising during the next five years to build its name-brand.
While such large sums of money are neither good nor bad in and of themselves, they do show that as new media grow in reach and influence, they will be subject to all the same commercial pressures as are the 4-color print magazines and TV networks. In this regard, it is perhaps instructive that the former Surgeon-General himself has already had a dust-up with The New York Times and others 3 over several Web-related policies, including his personal share of revenues from the sale of health products and services (Dr. Koop changed drkoop.com's policies to forego a 2 to 4% personal commission on sales).
Notwithstanding the growing role of commerce, the primary concern to date of most researchers has been the uneven, unreliable quality of health information found on the Internet. In 1997, for example, Impicciatore et al. reported that only four of 41 consumer-oriented Web sites they surveyed correctly reflected consensus recommendations on how to manage children's fevers. 4 Nor have attempts to introduce some standard quality indicators met with much success. In a 1998 JAMA article, 5 Jadad and Gagliardi, after reviewing no fewer than 47 rating instruments designed to serve as good-quality seals of approval for World Wide Web health sites, concluded that all were inadequate: "It is unclear . . . whether they should exist in the first place, whether they measure what they claim to measure, or whether they lead to more good than harm."
In the meantime, in new media as in old, the concluding observations of Bell et al. have undeniable cogency. Given that consumers' desire for medical information seems all but "insatiable," there is a continuing need for trustworthy communication by managed care organizations and for scrutiny of advertising claims by the FDA and physicians. And, as Wilson et al. point out in their careful analysis of a nurse's telephone script on acute respiratory illnesses, health professionals must not take it for granted that patients share their knowledge or their assumptions. Jadad notes in a recent paper that there is, as yet, little evidence in the published literature-much less in practice, with the rare exception of the Cochrane Collaboration-of the new partnership between physician and patient that many look to the Internet to foster. 6 Even with the best of intentions, the process of communication between professional and consumer remains problematic and in need of continual review and refinement.-R ON S AUDER , Editor, Interactive Healthcare Report, Frederick, Maryland.
